CAS 156856-30-3

156856-30-3 5,5-Dihydro-5-methyl-6-(1,5-dimethyl-6-hydroxy-4-(phosphoryloxy)trideca-7,9,11-trienyl)-2H-pyran-2-one (sodium salt) sodium (8Z,10Z,12E)-7-hydroxy-6-methyl-2-(3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)tetradeca-8,10,12-trien-5-yl hydrogenphosphate

纯度 97%+现货药物标准品
CAS 号156856-30-3
分子式C21H32O7P Na
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

156856-30-3 5,5-Dihydro-5-methyl-6-(1,5-dimethyl-6-hydroxy-4-(phosphoryloxy)trideca-7,9,11-trienyl)-2H-pyran-2-one (sodium salt) sodium (8Z,10Z,12E)-7-hydroxy-6-methyl-2-(3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)tetradeca-8,10,12-trien-5-yl hydrogenphosphate CAS 156856-30-3 结构式 Chemical Structure

产品介绍 Description

（156856-30-3 5,5-Dihydro-5-methyl-6-(1,5-dimethyl-6-hydroxy-4-(phosphoryloxy)trideca-7,9,11-trienyl)-2H-pyran-2-one (sodium salt) sodium (8Z,10Z,12E)-7-hydroxy-6-methyl-2-(3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)tetradeca-8,10,12-trien-5-yl hydrogenphosphate）是药物分析与质量控制领域常用的药物标准品，CAS 号 156856-30-3。分子式 C21H32O7P Na。纯度 97%+。CATO 佳途拥有 130,000+ 标准品现货目录，可一站式满足配套采购需求。

（156856-30-3 5,5-Dihydro-5-methyl-6-(1,5-dimethyl-6-hydroxy-4-(phosphoryloxy)trideca-7,9,11-trienyl)-2H-pyran-2-one (sodium salt) sodium (8Z,10Z,12E)-7-hydroxy-6-methyl-2-(3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)tetradeca-8,10,12-trien-5-yl hydrogenphosphate），CAS注册编号 156856-30-3，化学分子式为 C21H32O7P Na，分子量 450.44 g/mol。 依据分子式为 C21H32O7P Na 的结构特征，其分子内含含磷酸酯基，羧酸类，含羟基，含醚键，这意味着该化合物在紫外光谱中会呈现特征性的吸收带。分子量 450.44 g/mol 这一参数对质谱检测中的分子离子峰识别具有直接参考价值。分子中包含芳环或共轭体系，在UV-Vis光谱中具有特征性吸收带，适用于紫外或二极管阵列检测器（DAD）的定量分析。 在定量

应用场景：（156856-30-3 5,5-Dihydro-5-methyl-6-(1,5-dimethyl-6-hydroxy-4-(phosphoryloxy)trideca-7,9,11-trienyl)-2H-pyran-2-one (sodium salt) sodium (8Z,10Z,12E)-7-hydroxy-6-methyl-2-(3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)tetradeca-8,10,12-trien-5-yl hydrogenphosphate）作为药物标准品，在化学分析分析领域承担着重要的角色。 推荐以配制标准系列工作溶

理化性质 Physical & Chemical Properties

中文名称
分子式C21H32O7P Na
分子量450.44 g/mol
外观形态类白色至淡黄色结晶性粉末
纯度97%+
储存条件室温保存，避光，密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水（微溶）
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）6.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）2001年

相关专利 Related Patents

  1. 发明人沈红梅，黄志刚，罗永刚. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 116298897 A, 授权公告日 2022-06-01.
  2. 发明人高志强，唐晓军，周伟. "Method for the Synthesis of 156856-30-3 5,5-Dihydro-5-methyl-6-(1,5-dimethyl-6-hydroxy-4-(phosphoryloxy)trideca-7,9,11-trienyl)-2H-pyran-2-one (sodium salt) sodium (8Z,10Z,12E)-7-hydroxy-6-methyl-2-(3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)tetradeca-8,10,12-trien-5-yl hydrogenphosphate" [P]. 中国发明专利, 专利号 CN 110876637 B, 授权公告日 2022-12-22.

参考文献 Literature

  1. Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2023, 1948, (5), 6020-6024.
  2. Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2022, 266, (9), 6018-6030.
  3. Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 156856-30-3 5,5-Dihydro-5-methyl-6-(1,5-dimethyl-6-hydroxy-4-(phosphoryloxy)trideca-7,9,11-trienyl)-2H-pyran-2-one (sodium salt) sodium (8Z,10Z,12E)-7-hydroxy-6-methyl-2-(3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)tetradeca-8,10,12-trien-5-yl hydrogenphosphate Using HRMS and NMR". J. Pharm. Biomed. Anal., 2024, 677, (9), 5075-5103.

Related Dihydro Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...